GENA-99 Hemophilia A

Bleeding and Clotting Disorders

Protocol:GENA-99

Condition or Disease: Hemophilia A

Study Type: Observational

Status: Open for enrollment

Study Title: Prospective, multinational, non-interventional post-authorisation study to document the long-term immunogenicity, safety, and efficacy of Human-cl rhFVIII (simoctocog alfa) in patients with haemophilia A treated in routine clinical practice

Principal I investigator: Joseph Lasky III, MD

More Info: //clinicaltrials.gov/ct2/show/NCT02962765

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

Explore More News